Tag

Glp 1

All articles tagged with #glp 1

business3 hours ago•4 min saved

GLP-1 pricing heat rises as obesity drugs expand market at JPMorgan

At the JPMorgan Healthcare Conference, Novo Nordisk signals 2026 will bring price pressure as GLP-1 supply grows and pricing deals take effect, even as it pushes the Wegovy oral pill and expands the incretin market. Bristol Myers Squibb projects up to 10 new products by 2030 to counter upcoming exclusivity losses, while Pfizer insists it is “all in on obesity” and plans multiple late‑stage obesity studies tied to Metsera. The conference also features news such as Lilly and Nvidia jointly funding an AI drug‑discovery lab and AbbVie striking a price‑reduction deal with the Trump administration plus a RemeGen cancer-therapy license.

via CNBC|

#business #drug-pricing #glp-1

health1 day ago•1 min saved

FDA seeks to drop suicide risk warnings on GLP-1 weight-loss drugs

The FDA asked manufacturers of GLP-1 weight-loss drugs (Wegovy, Zepbound, Saxenda) to remove label warnings about suicidal thoughts after reviewing 91 trials with 107,910 patients and finding no evidence of increased suicidal thoughts, behavior, or other psychiatric effects versus placebo, though earlier data could not completely rule out a small risk.

via CNBC|

#drug-safety #fda #glp-1

health3 days ago•52 min saved

Ozempic muscle-loss risk prompts medical guidance for mitigation

Health experts warn that GLP-1 weight-loss drugs like Ozempic can cause substantial lean-mass loss in a sizable portion of users, potentially accelerating sarcopenia and increasing fall risk, especially among older adults; however, doctors advise mitigating strategies such as high-protein diets, regular strength training, and close medical follow-up to preserve muscle while maintaining weight-loss benefits.

via Daily Mail|

#glp-1 #health #muscle-loss

health4 days ago•3 min saved

Weight Regain Common Within Two Years After Stopping GLP-1 and Similar Obesity Drugs

A study from the University of Oxford found that stopping GLP-1 receptor agonist drugs like Wegovy and Ozempic leads to rapid weight regain and loss of health benefits within about 1.4 to 1.7 years, highlighting the need for comprehensive, long-term weight management strategies rather than short-term medication use.

via Futurism|

#glp-1 #health #health-benefits

health5 days ago•2 min saved

Weight and health risks rebound within two years after stopping GLP-1 medications

Research from Oxford indicates that stopping GLP-1 medications like Ozempic often results in weight regain within 18-24 months, highlighting obesity as a chronic condition requiring long-term management rather than short-term medication use.

via Scripps News|

#glp-1 #health #medication

health5 days ago•0 min saved

Weight Regain Common Within Two Years After Stopping GLP-1 Treatments

A study shows that individuals who stop using GLP-1 drugs like Ozempic and Wegovy tend to regain their lost weight within about 18 months, and those who used these drugs regain weight four times faster than those relying solely on diet and exercise. For long-term health benefits, lasting lifestyle changes are essential.

via The Washington Post|

#glp-1 #health #ozempic

health6 days ago•1 min saved

GLP-1 users regain weight after 18 months, study finds

A review of research indicates that individuals who stop using GLP-1 drugs like Ozempic and Wegovy for weight loss tend to regain their lost weight within approximately 18 months, and this regain occurs faster than with behavioral methods like dieting or exercise. To maintain health benefits after discontinuing these medications, lasting lifestyle changes are essential.

via The Boston Globe|

#glp-1 #health #ozempic

health9 days ago•3 min saved

Novo Nordisk Launches First GLP-1 Weight-Loss Pill in the U.S.

Novo Nordisk launches the first oral GLP-1 pill for weight loss in the U.S., offering a more affordable and accessible alternative to injections, with prices ranging from $149 to $299 per month, and aims to capture a significant share of the growing obesity treatment market.

via CNBC|

#glp-1 #health #novo-nordisk

health9 days ago•12 min saved

Novo Nordisk's Wegovy® oral pill for weight loss now widely available in the U.S.

Novo Nordisk's Wegovy® pill, the first oral GLP-1 medication for weight loss, is now widely available across US pharmacies and telehealth providers, offering an effective option for adults with obesity or overweight with medical issues, with an average weight loss of about 17% if all patients stay on treatment.

via PR Newswire|

#glp-1 #health #novo-nordisk

health10 days ago•2 min saved

Risks for People Discontinuing GLP-1s

Many individuals using GLP-1 drugs like Ozempic struggle to stop using them due to intense hunger and weight regain, suggesting a potential lifelong dependency. While some can maintain weight loss through lifestyle changes, others face significant challenges in discontinuing the medication, raising concerns about addiction and the need for ongoing treatment for obesity.

via Futurism|

#dependency #glp-1 #health

health10 days ago•2 min saved

Risks of Discontinuing GLP-1s Revealed

Many users of GLP-1 drugs like Ozempic struggle to stop using them due to intense hunger and weight regain, suggesting a potential lifelong dependency. While some, like Ellen Ogley, maintain weight loss through lifestyle changes, others experience significant weight regain, highlighting the importance of healthy habits during treatment. Experts recommend developing an exit strategy that includes lifestyle modifications to sustain weight loss after discontinuing the medication.

via Yahoo News New Zealand|

#dependency #glp-1 #health

health13 days ago•4 min saved

Doctors Discover Heart Benefits of Semaglutide

A study suggests that semaglutide may protect the heart independently of weight loss, potentially through direct effects on cardiovascular health, with benefits observed across different weight groups and linked partly to reduced waist size, indicating broader uses for the drug beyond weight management.

via SciTechDaily|

#cardiovascular #glp-1 #health

business13 days ago•0 min saved

2026 Set to Transform Weight Loss with New GLP-1 Drugs and Market Shifts

The article discusses the expected rise of GLP-1 weight loss pills in 2026 and how certain stocks in the healthcare sector are poised to benefit from this trend and the development of new habits related to weight management.

via CNBC|

#2026 #business #glp-1

health15 days ago•2 min saved

Psychiatrist Discusses Psychological Side Effects of GLP-1

A psychiatrist highlights that GLP-1 medications, while effective for metabolic health and weight loss, may have psychological side effects such as diminished motivation, reduced emotional vitality, and altered personality traits, emphasizing the need for careful monitoring of emotional and mental well-being alongside physical health.

via KevinMD.com|

#glp-1 #health #medications

health15 days ago•3 min saved

Oprah Shares Her Journey to Sobriety and Health with GLP-1s

Oprah Winfrey revealed she stopped using GLP-1 weight loss medication after 12 months, learning that maintaining weight loss with medication is a lifelong commitment. She shared her journey of understanding obesity as a condition influenced by genetics and environment, emphasizing the importance of compassion and accurate information in addressing obesity. Winfrey also discussed her new book on health and weight management.

via Yahoo|

#glp-1 #health #medication